Key Market Indicators
Chilean antihypertensive medicine sales are on the rise, projected to reach $15 million by 2026. In 2021, Chile's sales amounted to $12 million, representing an 11.8% year-on-year growth since 2005. Norway topped the rankings with $12 million, followed by Italy, Spain and Australia.
